P

PreciseDx alternatives and competitors

The closest alternatives to PreciseDx are Stratipath, ArteraAI, Imagene AI and Waiv.

PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide.

The list

10 alternatives to PreciseDx

What each product does, with its price as the vendor publishes it.

  1. S

    Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe.

    Price: No published price

  2. A

    ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. It is unrelated to Artera of Santa Barbara (artera.io), which makes patient communication agents.

    Price: No list price published; patient cost $0 to $285 under the financial assistance program, and none for covered Medicare patients

  3. I

    Imagene AI reads routine stained lung cancer slides and predicts which gene changes a tumor carries, without using more tissue for sequencing.

    Price: No published price

  4. W

    Waiv sells AI tests that read routine H&E slides, for pathology laboratories and oncology teams in Europe, and biomarker services for drug developers.

    Price: No published price

  5. V

    Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.

    Price: No published price

  6. P

    Cleo Breast and Cleo Skin are AI tools for clinical pathology laboratories in Europe that detect and quantify cancer features in whole slide images.

    Price: No published price

  7. D

    Histotype Px Colorectal predicts recurrence and survival in stage II and III colorectal cancer from standard H and E stained slides, placing patients in low, intermediate or high risk groups to inform whether adjuvant chemotherapy should follow surgery.

    Price: No published price

  8. L

    Lunit SCOPE is the pathology AI line of Lunit, the Seoul medical AI company. Drug companies, contract research organizations and digital pathology platforms use it to measure cancer biomarkers on tissue slides for research and trials.

    Price: No published price

  9. Q

    Qritive builds both an image management platform and the AI modules that run in it, and sells the modules into other companies' platforms too.

    Price: No pricing published. Platform and AI modules are both quoted, unit of charge unstated

  10. B

    Biomy makes DeepPathFinder, cloud software that uses AI to map immune and cancer cells on tissue slides for drug research.

    Price: No published price

Questions

PreciseDx alternatives, answered

What are the best alternatives to PreciseDx?

The closest alternatives to PreciseDx are Stratipath, ArteraAI, Imagene AI, Waiv and Veracyte. Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe. ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. Imagene AI reads routine stained lung cancer slides and predicts which gene changes a tumor carries, without using more tissue for sequencing.

Who are PreciseDx's competitors?

PreciseDx's competitors in the Digital Pathology AI category include Stratipath, ArteraAI, Imagene AI, Waiv, Primaa and DoMore Diagnostics.